Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
Stone GG, Bradford PA, Tawadrous M, Taylor D, Cadatal MJ, Chen Z, Chow JW. Stone GG, et al. Among authors: taylor d. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02356-19. doi: 10.1128/AAC.02356-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32071051 Free PMC article. Clinical Trial.
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.
Torres A, Zhong N, Pachl J, Timsit JF, Kollef M, Chen Z, Song J, Taylor D, Laud PJ, Stone GG, Chow JW. Torres A, et al. Among authors: taylor d. Lancet Infect Dis. 2018 Mar;18(3):285-295. doi: 10.1016/S1473-3099(17)30747-8. Epub 2017 Dec 16. Lancet Infect Dis. 2018. PMID: 29254862 Free article. Clinical Trial.
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.
Torres A, Rank D, Melnick D, Rekeda L, Chen X, Riccobene T, Critchley IA, Lakkis HD, Taylor D, Talley AK. Torres A, et al. Among authors: taylor d. Open Forum Infect Dis. 2019 Apr 25;6(4):ofz149. doi: 10.1093/ofid/ofz149. eCollection 2019 Apr. Open Forum Infect Dis. 2019. PMID: 31041348 Free PMC article.
DNA targeting by compact Cas9d and its resurrected ancestor.
Ocampo RF, Bravo JPK, Dangerfield TL, Nocedal I, Jirde SA, Alexander LM, Thomas NC, Das A, Nielson S, Johnson KA, Brown CT, Butterfield CN, Goltsman DSA, Taylor DW. Ocampo RF, et al. Among authors: taylor dw. Nat Commun. 2025 Jan 7;16(1):457. doi: 10.1038/s41467-024-55573-4. Nat Commun. 2025. PMID: 39774105 Free PMC article.
Characterizing the Effect of Repetitive Head Impact Exposure and mTBI on Adolescent Collision Sports Players' Brain with Diffusion Magnetic Resonance Imaging.
Tayebi M, Kwon E, McGeown J, Potter L, Taylor D, Condron P, Qiao M, McHugh P, Maller J, Nielsen P, Wang A, Fernandez J, Scadeng M, Shim V, Holdsworth S. Tayebi M, et al. Among authors: taylor d. J Neurotrauma. 2024 Dec 23. doi: 10.1089/neu.2024.0064. Online ahead of print. J Neurotrauma. 2024. PMID: 39714998
9,232 results